Immuno-Biological Laboratories Co., Ltd. (TYO:4570)

TYO:4570 Revenue

Immuno-Biological Laboratories had revenue of 274.00M JPY in the quarter ending September 30, 2025, with 27.44% growth. This brings the company's revenue in the last twelve months to 1.01B, up 12.85% year-over-year. In the fiscal year ending March 31, 2025, Immuno-Biological Laboratories had annual revenue of 969.00M with 18.75% growth.

• Revenue (ttm): 1.01B
• Revenue Growth: +12.85%
• P/S Ratio: 13.98
• Revenue / Employee: 17.41M
• Employees: 58
• Market Cap: 14.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	969.00M	153.00M	18.75%
Mar 31, 2024	816.00M	22.00M	2.77%
Mar 31, 2023	794.00M	147.00M	22.72%
Mar 31, 2022	647.00M	45.00M	7.48%
Mar 31, 2021	602.00M	26.00M	4.51%